MedTrace Logo

Trial of Protein Supplement on Vertebral Fusion in Posterior Spine Fusion Surgery

NCT04091841 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-11-30

No results posted yet for this study

Summary

Receiving protein can affect the bone formation and maintenance by providing a structural matrix of the bone, optimizing the level of IGF-1, increasing intestinal calcium absorption, transferring phosphorous, and improving muscle strength.Therefore, protein may be effective on vertebral fusion by such mechanisms. In this trial patients undergoing elective posterior spine fusion surgery are divided into two groups of intervention or control.

Conditions

  • Spine Surgery

Interventions

DRUG

protein supplement

Three sachet of protein supplement to be mixed in with water used daily.

OTHER

Carbo Mass

Three sachet of Carbo Mass supplement to be mixed in with water used daily.

Sponsors & Collaborators

  • Shahid Beheshti University

    lead OTHER

Principal Investigators

  • zahra vahdat shariatpanahi, MD,PhD · Faculty of Nutrition and Food Technology, SBMU

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2020-10-01
Completion
2020-10-01

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04091841 on ClinicalTrials.gov